parp inhibitor olaparib as treatment for pancreatic cancer patients with brca gene mutations
Published 5 years ago • 467 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
4:47
maintenance therapy with parp inhibitor olaparib delays progression in patients with brca-relate...
-
3:50
[pancreas] role of olaparib in stage 4 pancreatic cancer patients with brca mutations
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
1:32
parp inhibitor olaparib exceeds expectations in brca pancreatic cancer management
-
5:40
parp inhibitor combo shows early promise for patients with and without brca mutations
-
10:42
brca pancreatic cancer maintenance debate: parp inhibitor or continued chemo? - parp inhibitor
-
3:37
olaparib in metastatic pancreatic cancer, the polo trial
-
3:29
polo: maintenance olaparib in brca1/2 metastatic pancreatic cancer
-
4:19
treating brca breast cancer with parp inhibition
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer
-
3:26
different treatment strategies for brca positive breast cancer
-
1:58
discussing targeted treatment with parp inhibitors for brca-mutant patients across tumor types
-
1:41
parp inhibitors are a promising alternative to chemotherapy for patients with metastatic brca1 a...
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
3:26
new treatment on the horizon | parp inhibitor - olaparib
-
8:19
maintenance therapy with parp inhibitor olaparib delays progression of brca-related pancreatic c...
-
1:54
apollo: olaparib in pancreatic cancer with a brca1/2 or palb2 mutation
-
6:19
chemosymposium 2011: parp treatment for brca mutated and triple negative breast cancer
-
3:30
comment: it is essential to identify the brca gene in pancreatic cancer patients allowing them t...